Novartis to acquire worldwide adult medical nutrition business of

 

                 Transaction offers Novartis entry to U.S. retail medical nutrition channel and enhanced access to Japanese market

 

                 Established brands like Boost®, Isocal® and Ultracal® acquired to meet growing needs of outpatient and ageing population

 

Basel, Switzerland, December 16, 2003 - Novartis announced today its intention to acquire the brands, trademarks, patents and intellectual property assets of Mead Johnson & Company's global adult medical nutrition business in a US $385 million cash transaction.  Mead Johnson & Company, a subsidiary of Bristol-Myers Squibb Company, is a leader in sales and marketing of adult medical nutrition products.

 

Please see foll press release under the following link: